Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Computed Tomography | Case report

Acute fibrinous and organizing pneumonia complicated with hemophagocytic lymphohistiocytosis caused by chronic active Epstein-Barr virus infection: a case report

Authors: Xiaojing Wu, Kejing Wang, Yayue Gao, Ying Cai, Wenqiao Wang, Dingrong Zhong, Qingyuan Zhan

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Acute fibrinous and organizing pneumonia (AFOP) is a rare lung condition that is associated with acute lung injury. Its etiology may be idiopathic or secondary to a series of conditions, including immune-related diseases, unclassified connective tissue diseases, hematopoietic stem cell transplantation, infections, hematological diseases and drug induced lung toxicity. We report for the first time a case of AFOP complicated with hemophagocytic lymphohistiocytosis (HLH) caused by chronic active Epstein-Barr virus (CAEBV) infection.

Case presentation

A 64-year-old man was admitted with a complaint of fever and dyspnea for 2 weeks. The patient presented with elevated serum aminotransferase levels, splenomegaly, progressive decrease of red blood cells and platelets, hyperferritinemia, hypofibrinogenemia, and elevated of Soluble interleukin-2 receptor (sCD25). His chest computed tomography (CT) scan revealed multiple patchy consolidation in both lungs and multiple lymphadenopathy in the mediastinum and hilum. The serology for antibodies of VCA-IgG was positive, EBV-DNA in peripheral blood was elevated, and EBV nucleic acid was detected in the alveolar lavage fluid. Histopathology of the lung tissue showed a dominant of intra-alveolar fibrin and organizing pneumonia. Hemophagocytic cells was found in the bone marrow smear and biopsy. EBV-DNA was detected in lung tissue and bone marrow using in situ hybridization with an EBV-encoded RNA (EBER) probe. After 50 days of hospitalization, he was improved in lung and hemogram.

Conclusion

We report a case of AFOP with HLH caused by CAEBV in an immunocompetent adult, suggesting that AFOP may be a rare but serious complication caused by CAEBV, and glucocorticoid therapy may improve short-term prognosis.
Literature
1.
go back to reference Gomes R, Padrao E, Dabo H, Soares Pires F, Mota P, Melo N, Jesus JM, Cunha R, Guimaraes S, Souto Moura C, et al. Acute fibrinous and organizing pneumonia: a report of 13 cases in a tertiary university hospital. Medicine. 2016;95(27):e4073.CrossRef Gomes R, Padrao E, Dabo H, Soares Pires F, Mota P, Melo N, Jesus JM, Cunha R, Guimaraes S, Souto Moura C, et al. Acute fibrinous and organizing pneumonia: a report of 13 cases in a tertiary university hospital. Medicine. 2016;95(27):e4073.CrossRef
2.
go back to reference Otto C, Huzly D, Kemna L, Huttel A, Benk C, Rieg S, Ploenes T, Werner M, Kayser G. Acute fibrinous and organizing pneumonia associated with influenza A/H1N1 pneumonia after lung transplantation. BMC Pulm Med. 2013;13:30.CrossRef Otto C, Huzly D, Kemna L, Huttel A, Benk C, Rieg S, Ploenes T, Werner M, Kayser G. Acute fibrinous and organizing pneumonia associated with influenza A/H1N1 pneumonia after lung transplantation. BMC Pulm Med. 2013;13:30.CrossRef
3.
go back to reference Heo JY, Song JY, Noh JY, Yong HS, Cheong HJ, Kim WJ. Acute fibrinous and organizing pneumonia in a patient with HIV infection and Pneumocystis jiroveci pneumonia. Respirology (Carlton, Vic). 2010;15(8):1259–61.CrossRef Heo JY, Song JY, Noh JY, Yong HS, Cheong HJ, Kim WJ. Acute fibrinous and organizing pneumonia in a patient with HIV infection and Pneumocystis jiroveci pneumonia. Respirology (Carlton, Vic). 2010;15(8):1259–61.CrossRef
4.
go back to reference Cincotta DR, Sebire NJ, Lim E, Peters MJ. Fatal acute fibrinous and organizing pneumonia in an infant: the histopathologic variability of acute respiratory distress syndrome. Pediatric Crit Care Med. 2007;8(4):378–82. Cincotta DR, Sebire NJ, Lim E, Peters MJ. Fatal acute fibrinous and organizing pneumonia in an infant: the histopathologic variability of acute respiratory distress syndrome. Pediatric Crit Care Med. 2007;8(4):378–82.
5.
go back to reference Okano M. Haematological associations of Epstein-Barr virus infection. Bailliere’s Best Practice & Res Clin Haematol. 2000;13(2):199–214.CrossRef Okano M. Haematological associations of Epstein-Barr virus infection. Bailliere’s Best Practice & Res Clin Haematol. 2000;13(2):199–214.CrossRef
6.
go back to reference Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD. The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol. 2015;33:787–821.CrossRef Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD. The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol. 2015;33:787–821.CrossRef
7.
go back to reference Ramachandran S, Zaidi F, Aggarwal A, Gera R. Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis. Blood Cells Mol Dis. 2017;64:53–7.CrossRef Ramachandran S, Zaidi F, Aggarwal A, Gera R. Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis. Blood Cells Mol Dis. 2017;64:53–7.CrossRef
8.
go back to reference Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.CrossRef Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.CrossRef
9.
go back to reference Kim JY, Doo KW, Jang HJ. Acute fibrinous and organizing pneumonia: imaging features, pathologic correlation, and brief literature review(). Radiol Case Rep. 2018;13(4):867–70.CrossRef Kim JY, Doo KW, Jang HJ. Acute fibrinous and organizing pneumonia: imaging features, pathologic correlation, and brief literature review(). Radiol Case Rep. 2018;13(4):867–70.CrossRef
10.
go back to reference Beasley MB, Franks TJ, Galvin JR, Gochuico B, Travis WD. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med. 2002;126(9):1064–70.CrossRef Beasley MB, Franks TJ, Galvin JR, Gochuico B, Travis WD. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med. 2002;126(9):1064–70.CrossRef
11.
go back to reference Rickinson AB. Chronic, symptomatic Epstein-Barr virus infections. Immunol Today. 1986;7(1):13–4.CrossRef Rickinson AB. Chronic, symptomatic Epstein-Barr virus infections. Immunol Today. 1986;7(1):13–4.CrossRef
12.
go back to reference Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001;98(2):280–6.CrossRef Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001;98(2):280–6.CrossRef
13.
go back to reference Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673–86.CrossRef Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673–86.CrossRef
14.
go back to reference Paik JH, Choe JY, Kim H, Lee JO, Kang HJ, Shin HY, Lee DS, Heo DS, Kim CW, Cho KH, et al. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Leuk Lymphoma. 2017;58(1):53–63.CrossRef Paik JH, Choe JY, Kim H, Lee JO, Kang HJ, Shin HY, Lee DS, Heo DS, Kim CW, Cho KH, et al. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Leuk Lymphoma. 2017;58(1):53–63.CrossRef
15.
go back to reference Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol. 2005;80(1):64–9.CrossRef Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol. 2005;80(1):64–9.CrossRef
16.
go back to reference Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol. 2006;16(4):251–61.CrossRef Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol. 2006;16(4):251–61.CrossRef
17.
go back to reference Ankermann T, Claviez A, Wagner HJ, Krams M, Riedel F. Chronic interstitial lung disease with lung fibrosis in a girl: uncommon sequelae of Epstein-Barr virus infection. Pediatr Pulmonol. 2003;35(3):234–8.CrossRef Ankermann T, Claviez A, Wagner HJ, Krams M, Riedel F. Chronic interstitial lung disease with lung fibrosis in a girl: uncommon sequelae of Epstein-Barr virus infection. Pediatr Pulmonol. 2003;35(3):234–8.CrossRef
18.
go back to reference Joo EJ, Ha YE, Jung DS, Cheong HS, Wi YM, Song JH, Peck KR. An adult case of chronic active Epstein-Barr virus infection with interstitial pneumonitis. Korean J Intern Med. 2011;26(4):466–9.CrossRef Joo EJ, Ha YE, Jung DS, Cheong HS, Wi YM, Song JH, Peck KR. An adult case of chronic active Epstein-Barr virus infection with interstitial pneumonitis. Korean J Intern Med. 2011;26(4):466–9.CrossRef
19.
go back to reference Roliński J, Grywalska E, Pyzik A, Dzik M, Opoka-Winiarska V, Surdacka A, Maj M, Burdan F, Pirożyński M, Grabarczyk P, et al. Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia—case report. BMC Infect Dis. 2018;18(1):190.CrossRef Roliński J, Grywalska E, Pyzik A, Dzik M, Opoka-Winiarska V, Surdacka A, Maj M, Burdan F, Pirożyński M, Grabarczyk P, et al. Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia—case report. BMC Infect Dis. 2018;18(1):190.CrossRef
Metadata
Title
Acute fibrinous and organizing pneumonia complicated with hemophagocytic lymphohistiocytosis caused by chronic active Epstein-Barr virus infection: a case report
Authors
Xiaojing Wu
Kejing Wang
Yayue Gao
Ying Cai
Wenqiao Wang
Dingrong Zhong
Qingyuan Zhan
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06868-0

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.